Search

everythinglearnresearchcommunity

for

Search:↓

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Modulating the BTNL2 pathway can prevent hair loss in mice.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

FoxN1 overexpression in young mice harms immune cell and skin development.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Fractional radiofrequency microneedling is as effective and safe as intralesional steroids for treating patchy alopecia areata, with fewer side effects.

M-CSF-stimulated myeloid cells can turn into skin cells and help heal wounds and regrow hair.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

FOL-026 peptide may help hair growth and cardiovascular health by improving blood flow and cell functions.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

Early changes in skin gene expression can predict later bone mass loss after radiation exposure.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Hair follicle stem cells may help treat strokes.

Targeting regulatory T cells may help treat age-related diseases.